ENDONOVO THERAPEUTICS, INC. Quarterly Common Stock, Shares, Issued from Q4 2010 to Q3 2023

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Endonovo Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q3 2023.
  • Endonovo Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2023 was 319M shares, a 100% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 319M +160M +100% Sep 30, 2023 10-Q/A 2023-12-29
Q2 2023 279M +128M +85.3% Jun 30, 2023 10-Q 2023-08-21
Q1 2023 270M +189M +232% Mar 31, 2023 10-Q 2023-05-22
Q4 2022 213M +139M +186% Dec 31, 2022 10-Q/A 2023-12-29
Q3 2022 159M +90M +130% Sep 30, 2022 10-Q 2022-11-21
Q2 2022 150M +89.8M +148% Jun 30, 2022 10-Q 2022-08-22
Q1 2022 81.3M +29.8M +57.8% Mar 31, 2022 10-Q 2022-05-19
Q4 2021 74.5M +50M +204% Dec 31, 2021 10-K 2023-04-17
Q3 2021 69.2M +51.9M +300% Sep 30, 2021 10-Q 2021-11-19
Q2 2021 60.7M +53.4M +741% Jun 30, 2021 10-Q 2021-08-23
Q1 2021 51.5M +44.3M +614% Mar 31, 2021 10-Q 2021-05-24
Q4 2020 24.5M +23.3M +1963% Dec 31, 2020 10-K 2022-04-14
Q3 2020 17.3M -817M -97.9% Sep 30, 2020 10-Q 2020-11-19
Q2 2020 7.21M -723M -99% Jun 30, 2020 10-Q 2020-08-19
Q1 2020 7.21M -510M -98.6% Mar 31, 2020 10-Q 2020-06-12
Q4 2019 1.19M +758K +176% Dec 31, 2019 10-K 2021-04-13
Q3 2019 834M +453M +119% Sep 30, 2019 10-Q 2019-11-19
Q2 2019 731M +374M +105% Jun 30, 2019 10-Q 2019-08-13
Q1 2019 517M +179M +52.9% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 431K -317M -99.9% Dec 31, 2018 10-K 2020-05-04
Q3 2018 381M +97.3M +34.3% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 356M +112M +45.9% Jun 30, 2018 10-Q 2018-08-13
Q1 2018 338M +112M +49.8% Mar 31, 2018 10-Q 2018-05-18
Q4 2017 317M +183M +136% Dec 31, 2017 10-K 2019-04-15
Q3 2017 284M +159M +128% Sep 30, 2017 10-Q/A 2017-11-09
Q2 2017 244M +126M +107% Jun 30, 2017 10-Q 2017-08-10
Q1 2017 226M +117M +108% Mar 31, 2017 10-Q 2017-05-12
Q4 2016 134M +29.5M +28.2% Dec 31, 2016 10-K 2018-04-06
Q3 2016 125M +22.8M +22.4% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 118M +19.3M +19.6% Jun 30, 2016 10-Q 2016-08-12
Q1 2016 108M +11.9M +12.3% Mar 31, 2016 10-Q/A 2016-05-27
Q4 2015 105M +23.4M +28.7% Dec 31, 2015 10-K 2017-04-17
Q3 2015 102M Sep 30, 2015 10-Q 2015-11-23
Q2 2015 98.6M Jun 30, 2015 10-Q 2015-08-19
Q1 2015 96.4M Mar 31, 2015 10-Q/A 2015-06-15
Q4 2014 81.4M +80.6M +9684% Dec 31, 2014 10-K/A 2016-05-17
Q4 2013 832K -52.9M -98.5% Dec 31, 2013 10-K/A 2015-06-15
Q3 2013 75.8M +23.2M +44% Sep 30, 2013 10-Q 2013-12-18
Q2 2013 61.2M +11.3M +22.6% Jun 30, 2013 10-Q/A 2013-08-28
Q1 2013 61.2M +14.7M +31.6% Mar 31, 2013 10-Q/A 2013-06-21
Q4 2012 53.7M +15.4M +40.1% Dec 31, 2012 10-Q 2013-12-18
Q3 2012 52.7M Sep 30, 2012 10-Q 2012-11-29
Q2 2012 49.9M Jun 30, 2012 10-Q 2012-08-20
Q1 2012 46.5M Mar 31, 2012 10-Q 2012-05-21
Q4 2011 38.3M +33.8M +745% Dec 31, 2011 10-K/A 2013-05-03
Q4 2010 4.53M Dec 31, 2010 10-K 2012-04-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.